Vascular Disease Discovery Protocol
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Study ID
- NCT03538639
- Status
- Recruiting
Conditions
- Genetic Mutations
- Genetic Predisposition
- Vascular Dysfunction
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 100 Years
- Healthy Volunteers
- Accepted
Study Details
Background: Some genetic diseases put increase the risk of heart and blood diseases, which are the number one cause of death and disability in the U.S. Researchers want to study diseases of the heart and/or blood vessels. They want to collect data and specimens from affected people, their family members, and healthy people. Objective: To study diseases of the heart and/or blood vessels. Eligibility: People age 2 and older who may have genetic disease affecting the heart and/or blood vessels Their relatives Healthy volunteers Design: Participants will be screened with a medical history, physical exams, and imaging tests. Participants may have a few visits or visits for 2 weeks or more. This will depend on their age and disease status. Visits may include: Photographs of the face and body Heart tests Samples taken of blood, urine, saliva, skin, and/or tissue Scans. For some, a dye may be injected into a vein. A six-minute walk test Lung tests. For some, participants will blow into a tube. For others, they will breathe in a gas from a mask, have a small injection, then have a scan. Stress tests while walking on a treadmill or riding a stationary bike Ultrasound of veins and arteries Devices outside the body testing the stiffness and function of arteries Eye exam and eye tests. For some, a dye may be injected in a vein. Blood pressure tests Measurements of blood flow under the skin and in the arms and fingernail blood vessels Devices outside the body testing flexibility of the blood vessels and skin, and skin temperature
Key Dates
- Start date
- Jul 30, 2018
- Status verified
- Apr 2026
- Primary completion
- Nov 30, 2027
- Completion
- May 15, 2037
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: 1Adult index cases (affected) and relatives (affected and unaffected)
- Arm: 2Child index cases (affected) and child relatives (affected and unaffected)
- Arm: 3Healthy adult volunteers
Primary Outcome Measure
Rapid initiation of new, disease-specific investigations to enable the collection of data and biospecimens on affected subjects, their family members and healthy controls, and to assist in the generation of diagnoses and further the understandin... [ Time Frame: ongoing ]
Central Contacts
- William R Whalen, C.R.N.P.(301) 402-9841
- Manfred Boehm, M.D.(301) 435-7211
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 |
Find similar trials in Bethesda, MD
Related Studies
- Pancreas Registry and High Risk RegistryRecruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- DNA Methylation and Vascular FunctionRecruiting · University of Illinois at Chicago · Chicago, Illinois
- Genetic Investigation of Cancer PredispositionNot Yet Recruiting · The University of Texas Health Science Center at San Antonio · San Antonio, Texas
- Pancreatic Cancer Early Detection ConsortiumRecruiting · Arbor Research Collaborative for Health · Phoenix, Arizona